Cyclacel Pharma (CYCC) Misses Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.18). Revenue for the quarter came in at $10 thousand.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GTCR Is Said To Be In Talks To Buy Software Maker SPS Commerce - Bloomberg
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
- SEALSQ posts 131% revenue gain in H1 2026, net loss widens
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
